Breaks Categories: News

MondayFeb 24, 2020 11:59 am

NetworkNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) to Present at LD Micro Virtual Investor Conference on March 4

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced that management will present at the LD Micro Virtual Investor Conference at 1:00 p.m. Eastern Time on March 4, 2020. According to the update, Sigma Labs Executive Chairman, Mark K. Ruport, will present an overview of the business model and growth initiatives. A presentation will accompany the webinar, which will be followed by a question and answer session. To access the webinar, visit http://nnw.fm/m824P To view the full press release, visit http://nnw.fm/K9ouK About Sigma Labs Sigma Labs, Inc. (NASDAQ: SGLB) is…

Continue Reading

MondayFeb 24, 2020 11:23 am

NetworkNewsBreaks – Nightfood Holdings Inc.’s (NGTF) Ice Cream Now Formally Recommended by APA for Pregnancy-Related Cravings

Nightfood Holdings (OTCQB: NGTF), the better-for-you ice cream company addressing America’s $50 billion-dollar nighttime snacking market, has announced that the American Pregnancy Association (“APA”) is now formally recommending Nightfood as the ice cream expectant women should turn to when experiencing pregnancy-related cravings. A national health organization committed to promoting reproductive and pregnancy wellness through education, support, advocacy and community awareness, the APA currently serves over five million women and families a month through their website and toll-free education helpline. “Over 130,000 visitors daily turn to the APA website for information about pregnancy health, nutrition, preparing for the birth experience, naming…

Continue Reading

MondayFeb 24, 2020 10:51 am

NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Underwriters Exercise of Overallotment Option

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, today announced the exercise by the underwriters of the Company’s previously announced firm commitment underwritten offering which closed on February 18, 2020. According to the update, the exercise of the overallotment option and the underwriters purchase of 115,767 shares of common stock, each at the public offering price of $6.50, less the underwriters’ discount of $0.52 per share, resulted in net pricing of $5.98 per share. Trxade Group received approximately $0.7 million…

Continue Reading

MondayFeb 24, 2020 10:24 am

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Major CPG Company’s Results to Generate 6 to 1 ROAS and 4.5% Incremental Sales Lift Through Employment of BIGtoken

SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, today announced the release of a new case study. According to the update, the study illustrates results when one of the largest global food and beverage companies activated BIGtoken to drive sales during the 2019 holiday season. The campaign featured opt-in panels and BIGtoken platform offers, whereby users answered questions about the brand and category, scanned receipts and shared other data points about their consumer journey. The high-value insights were then used to create audiences and messaging strategy pre-activation, as well as optimize against these insights throughout the…

Continue Reading

MondayFeb 24, 2020 9:48 am

NetworkNewsBreaks – Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Announces the Change of its Name to Bolt Metals Corp.

Pacific Rim Cobalt (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) today announced that it has changed its name to Bolt Metals Corp., with an effective date on or about February 26, 2020. The Company’s shares will continue to trade under the stock symbol "BOLT" on the Canadian Securities Exchange (“CSE”). Similarly, there will be no change to the Company’s trading symbol on the Frankfurt Exchange or the OTCQB. The Company is not subdividing, consolidating or otherwise altering its share capital in association with the name change, which does not affect the rights of and does not require further action by the…

Continue Reading

FridayFeb 21, 2020 1:20 pm

NetworkNewsBreaks – Village Farms International, Inc. (NASDAQ: VFF) Featured in ROTH Equity Research Report

Village Farms International (NASDAQ: VFF) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “The Canadian cannabis market has been impacted by supply limitations, regulatory headwinds, and a thriving black market which we believe will persist through 1H20. We expect near-term exposure to weak Canadian wholesale pricing, but VFF's low-cost operations is built to survive commoditization; we expect high-cost LP production failures inevitable. Despite VFF brands gaining share at key provinces, continuing price pressure will impact VFF's top-line through 1H20. We are lowering 19/20 estimates and PT to $16.00, while maintaining our…

Continue Reading

FridayFeb 21, 2020 1:16 pm

NetworkNewsBreaks – eGain Corp. (NASDAQ: EGAN) Featured in ROTH Equity Research Report

eGain (NASDAQ: EGAN) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “EGAN's 2QF20 results were good, with revenues moderately above our forecast and adjusted operating income sharply above (at $2.6M versus our breakeven estimate). Updated F2020 guidance is mixed, seeing revenues at the lower-end of its prior guidance, but PF EPS is seen well above the prior guidance. Given good overall results in 1HF20, at odds with its recent severe valuation pressure, we reiterate our Buy rating and $15.00 price target.” To request access to the full report, visit http://nnw.fm/DXCr3 About…

Continue Reading

FridayFeb 21, 2020 1:12 pm

NetworkNewsBreaks – Pixelworks, Inc. (NASDAQ: PXLW) Featured in ROTH Equity Research Report

Pixelworks (NASDAQ: PXLW) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “We believe PXLW represents a differentiated investment opportunity in video display processing capabilities. Results in the quarter were in-line with expectations reflecting near-term demand weakness in projector and video delivery, with guidance below seasonal reflecting on-going inventory impact macro uncertainty. We are nonetheless very optimistic on the mobile revenue opportunity across both Iris smartphone ramp and TrueCut licensing. We expect other segments to recover in the mid-CY20 timeframe driving growth for the overall company. We maintain our Buy rating.” To…

Continue Reading

FridayFeb 21, 2020 12:35 pm

NetworkNewsBreaks – Arcus Biosciences, Inc. (NYSE: RCUS) Featured in Mizuho Securities Research Report

Arcus Biosciences (NYSE: RCUS) was featured in a recent U.S. Equity Research Report published by Mizuho Securities USA LLC. The report reads, “RCUS is trading up >20% today, which we believe is a result of the focus on TIGIT coming from RHHBY's (not covered) analyst meeting yesterday which highlighted the advancement of tiragolimab into Phase III (SKYSCRAPER-02) and discussion of its role as a novel immune checkpoint. RCUS is developing an anti-TIGIT mAb, AB154, which is currently in Phase II clinical studies, and we expect data disclosure in 4Q20 from this program. Our recent ‘Top of Mind’ note for RCUS…

Continue Reading

FridayFeb 21, 2020 12:31 pm

NetworkNewsBreaks – Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) Featured in Mizuho Securities Research Report

Xeris Pharmaceuticals (NASDAQ: XERS) was featured in a recent U.S. Equity Research Report published by Mizuho Securities USA LLC. The report reads, “We are lowering our 12-month price target to $18 from $22 and reaffirming our Buy rating on Xeris following its capital raise, completed on 2/11/20. The company issued 9 million shares, upsized from 6 mil, at $4.15 per share, raising approximately $37.4 mil prior to fees. We believe this should satisfy the company's capital requirements through 2H21, and expect another capital raise of $60 mil may be required to get Xeris to breakeven, which we continue to forecast…

Continue Reading